Logotype for Insight Molecular Diagnostics Inc

Insight Molecular Diagnostics (IMDX) investor relations material

Insight Molecular Diagnostics H.C. Wainwright 27th Annual Global Investment Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Insight Molecular Diagnostics Inc
H.C. Wainwright 27th Annual Global Investment Conference summary8 Sep, 2025

Market opportunity and strategy

  • Focus on transplant monitoring, a $2 billion U.S. clinical market, identified as underpenetrated and ripe for disruption due to inefficiencies and centralization at a few labs.

  • Plan to decentralize testing by enabling transplant centers to perform tests locally, capturing revenue and improving patient management.

  • Patent-protected workflow and high reimbursement rates create barriers to entry and attractive margins.

  • Global greenfield opportunity estimated at $1 billion for regulated transplant testing, with recurring revenue from frequent patient monitoring.

  • Partnerships with three of the top 10 U.S. transplant centers and Bio-Rad Laboratories support rapid market entry and adoption.

Product development and regulatory progress

  • Test is well-validated with over a decade of published research and cited in key reimbursement decisions.

  • Achieved $2,753 reimbursement per test and improved rates from Multi-X.

  • First patient enrolled in pivotal study; FDA submission expected by end of year, with potential approval and launch by mid-next year.

  • Head-to-head data shows equivalence with top competitors, supporting clinical adoption.

  • Registry and clinicaltrials.gov listing established to support data collection and payer engagement.

Financial outlook and partnerships

  • Bio-Rad Laboratories has made multiple equity investments and is closely aligned in regulatory and commercialization efforts.

  • Registry program may enable earlier-than-expected revenue next year, though no formal guidance provided.

  • Test manufacturing costs are low, enabling software-like margins and scalable global expansion.

  • Oncology pipeline includes DetermaCNI and DetermaIO, with current focus on research and potential future investment as cash flow grows.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Insight Molecular Diagnostics earnings date

Logotype for Insight Molecular Diagnostics Inc
Q3 202511 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Insight Molecular Diagnostics earnings date

Logotype for Insight Molecular Diagnostics Inc
Q3 202511 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

OncoCyte Corporation develops and markets molecular diagnostics for use in oncology and transplantation. The company focuses on liquid biopsy technologies and gene expression testing to support clinical decision-making in patient care. Its services are aimed at healthcare providers and research institutions. The company is headquartered in Irvine, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage